Chronic Respiratory Disease (Chron Respir Dis)

Publisher: SAGE Publications

Journal description

This timely new journal is a response to the rising incidence of chronic respiratory diseases worldwide. It will publish high quality research papers and original articles that have immediate relevance to clinical practice and its multi-disciplinary perspective reflects the nature of modern treatment. The journal will provide a high quality, multi-disciplinary focus for the publication of original papers, reviews and commentary in the broad area of chronic respiratory disease, particularly its treatment and management.

Current impact factor: 2.69

Impact Factor Rankings

2015 Impact Factor Available summer 2016
2014 Impact Factor 2.694
2013 Impact Factor 2.308

Additional details

5-year impact 0.00
Cited half-life 4.50
Immediacy index 0.24
Eigenfactor 0.00
Article influence 0.00
Website Chronic Respiratory Disease website
Other titles Chronic respiratory disease (Online)
ISSN 1479-9723
OCLC 56132568
Material type Document, Periodical, Internet resource
Document type Internet Resource, Computer File, Journal / Magazine / Newspaper

Publisher details

SAGE Publications

  • Pre-print
    • Author can archive a pre-print version
  • Post-print
    • Author can archive a post-print version
  • Conditions
    • Authors retain copyright
    • Pre-print on any website
    • Author's post-print on author's personal website, departmental website, institutional website or institutional repository
    • On other repositories including PubMed Central after 12 months embargo
    • Publisher copyright and source must be acknowledged
    • Publisher's version/PDF cannot be used
    • Post-print version with changes from referees comments can be used
    • "as published" final version with layout and copy-editing changes cannot be archived but can be used on secure institutional intranet
    • Must link to publisher version with DOI
    • Publisher last reviewed on 29/07/2015
  • Classification
    ​ green

Publications in this journal

  • [Show abstract] [Hide abstract]
    ABSTRACT: Pulmonary rehabilitation (PR) can improve aerobic exercise capacity, health-related quality of life and dyspnoea in patients with chronic obstructive pulmonary disease (COPD). Recent studies have suggested that exercise training may improve blood pressure and arterial stiffness, albeit in small highly selected cohorts. The aim of the study was to establish whether supervised outpatient or unsupervised home PR can reduce peripheral blood pressure. Resting blood pressure was measured in 418 patients with COPD before and after outpatient PR, supervised by a hospital-based team (HOSP). Seventy-four patients with COPD undergoing an unsupervised home-based programme acted as a comparator group (HOME). Despite significant improvements in mean (95% confidence interval) exercise capacity in the HOSP group (56 (50-60) m, p < 0.001) and HOME group (30 (17-42) m, p < 0.001) systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial blood pressure (MAP) did not change in either the HOSP (SBP: p = 0.47; DBP: p = 0.06; MAP: p = 0.38) or HOME group (SBP: p = 0.67; DBP: p = 0.38; MAP: p = 0.76). Planned subgroup analysis of HOSP patients with known hypertension and/or cardiovascular disease showed no impact of PR upon blood pressure. PR is unlikely to reduce blood pressure, and by implication, makes a mechanism of action in which arterial stiffness is reduced, less likely. © The Author(s) 2015.
    Chronic Respiratory Disease 05/2015; 12(3). DOI:10.1177/1479972315587515
  • Chronic Respiratory Disease 10/2013; 10(4):239-239. DOI:10.1177/1479972313501904
  • Chronic Respiratory Disease 10/2013; 10(4):235-235. DOI:10.1177/1479972313497374
  • Chronic Respiratory Disease 10/2013; 10(4):233-233. DOI:10.1177/1479972313501903
  • Chronic Respiratory Disease 10/2013; 10(4):237-237. DOI:10.1177/1479972313497373
  • Chronic Respiratory Disease 04/2013; 10(2):109-109. DOI:10.1177/1479972313485460
  • Chronic Respiratory Disease 04/2013; 10(2):109-109. DOI:10.1177/1479972313485459
  • Chronic Respiratory Disease 04/2013; 10(2):107-108. DOI:10.1177/1479972312474831
  • Chronic Respiratory Disease 01/2013; 10(1):55-55. DOI:10.1177/1479972312469977
  • Chronic Respiratory Disease 11/2012; 9(4):269-269. DOI:10.1177/1479972312458682
  • Chronic Respiratory Disease 07/2012; 9(3):205-205. DOI:10.1177/1479972312452440
  • [Show abstract] [Hide abstract]
    ABSTRACT: Chronic obstructive pulmonary disease (COPD) is a highly prevalent disease. Currently, severity Global initiative for chronic Obstructive Lung Disease (GOLD) criteria are used to diagnose the severity of COPD, but a new grading system, the body mass index, bronchial obstruction, dyspnea, exercise (BODE) index, was recently proposed to provide useful prognostic information. The objective of this study is to evaluate the association between health-related quality of life (HRQOL) and COPD severity assessed by two criteria: the GOLD classification and the BODE index. Sixty-four patients with COPD were examined with lung function tests and specific and generic HRQOL questionnaires (St. George's Respiratory Questionnaire [SGRQ], Nottingham Health Profile [NHP]). Participants were divided into four severity groups using the GOLD guidelines and the BODE index quartiles. The association between NHP and SGRQ subscales, and the BODE index was significant (P < 0.01). However, the GOLD classification shows a correlation only with SGRQ total score (P < 0.05) but not with NHP or SGRQ subscales. There was an association of the SGRQ total score between the severity groups of BODE (P = 0.0001), but there was no difference in the SGRQ total score between the severity groups of GOLD classification (P = 0.244). The present study suggests that COPD severity assessed by the BODE index can be more directly related with HRQOL.
    Chronic Respiratory Disease 02/2009; 6(2):75-80. DOI:10.1177/1479972308101551
  • [Show abstract] [Hide abstract]
    ABSTRACT: Excellent palliative care is available for patients with advanced lung cancer. Whether the same services are available for those with nonmalignant respiratory disease is less clear. A questionnaire was sent to 210 named respiratory physicians, each representing a major hospital in England, Wales, and Northern Ireland. A total of 107 replies were received; the response rate was 51.0%. Respondents cared for patients with chronic obstructive pulmonary disease, asbestosis, and diffuse parenchymal lung disease but only a third had responsibility for cystic fibrosis. Physicians were supported by a mean of 3.4 respiratory nurse specialists per department and 73.8% had a specialist lung cancer nurse. In only 16 cases (20.3%) did that nurse extend care to those with nonmalignant disease. Only a minority reported easy access to hospice in-patient care or day care. About 21.5% of the respondents had formal policies in place for care of patients with chronic respiratory disease nearing the end of life, but 87.9% of respondents had no formal process for initiating end of life discussions with those with terminal respiratory illness. Patients with advanced nonmalignant respiratory disease have less universal access to specialist palliative care services than do those with malignant lung disease, and in the majority of hospitals there is no formalized approach to end of life care issues with patients with chronic lung disease.
    Chronic Respiratory Disease 02/2009; 6(1):13-7. DOI:10.1177/1479972308100538
  • [Show abstract] [Hide abstract]
    ABSTRACT: Asthma is the most prevalent chronic disease in children. To quantify the national prevalence of asthma symptoms in Iranian children, we conducted a systematic review and meta-analysis. After internet and hand searching for population-based prevalence estimates published from 1998 to 2003 from 142 articles, dissertations and reports of research projects, 19 of them were selected. All the selected studies on children had been performed by the International Study of Asthma and Allergies in Childhood (ISAAC) protocol. We analyzed the data using NCSS software. In the included 19 studies, 61,067 children in different age groups had been examined by the ISAAC protocol. The lowest prevalence of asthma symptoms was 2.7% in Kerman and the highest was 35.4% in Tehran (capital of Iran). Overall prevalence of asthma symptoms at a national level was estimated as 13.14% (95% CI: 9.97-16.30%). Based on this study, the prevalence of asthma symptoms in Iran is higher than that estimated in the international reports. This information can be used to help prioritize asthma prevention and control within the range of Iranian public health concerns.
    Chronic Respiratory Disease 02/2009; 6(2):109-14. DOI:10.1177/1479972309103884
  • Chronic Respiratory Disease 02/2009; 6(3):175. DOI:10.1177/1479972309104663
  • Source
    Chronic Respiratory Disease 02/2009; 6(1):43-4. DOI:10.1177/1479972308098670